SUMMARY
INTRODUCTION
Bilirubin is the major metabolite of heme, which is found in hemoglobin, myoglobin, and cytochromes. Hyperbilirubinemia is the result of an imbalance between the production and excretion of bilirubin by the liver and can be found in hepatocellular disorders, hemolytic diseases, and cholestasis. The accurate determination of the type and level of bilirubin disorder in body fluids, especially serum, is important for diagnosis and for monitoring therapy [1] . Despite many different methods being available, the goal of obtaining a precise, accurate and specific measurement of bilirubin and its subfractions in serum has not yet been achieved [2, 3] . Furthermore, although traceability has been required in China to improve the quality of measurement, non-homogeneous systems for biochemistry analysis are still common in Chinese clinical laboratories [4, 5] . Consequently, reagent kits and/or calibrators may not match the automatic analyzers in many laboratories. For the above reasons, results of serum bilirubin measurements might have large variation for different methods in China. In this study, analytical performance and clinical results of three routine methods for the measurement of serum bilirubin, including diazo method, vanadate oxidase method, and dry chemistry method, were evaluated to find out the status of correlation and bias of different methods for bilirubin test in a Chinese laboratory.
MATERIALS AND METHODS
The constitution of three diagnostic systems Diazo method (Cobas 8000) Cobas 8000 analyzer (Roche, Germany), modular c701, was routinely used for inpatient samples detection. For both total bilirubin and direct bilirubin, reagent kits, calibrators, and quality control materials were purchased from Roche.
Vanadate oxidase method (the non-homogeneous system) It was performed on "open channels" of Cobas 8000. For both total bilirubin and direct bilirubin, the reagent kits were provided by Wako (Wako Pure Chemical industries, Ltd., Tokyo, Japan). Calibrators and quality control materials in this system were the same as for the diazo method mentioned above.
Dry chemistry method (Ortho VITROS 5600)
Ortho VITRO 5600 (Johnson-Johnson Co, USA), was used in the emergency department. Only for total bilirubin, the reagent kits, calibrators, and quality control materials were original from Johnson-Johnson.
Collection of comparison samples
Commercial control samples were used for determination of between-day imprecision. Fresh residual patients' samples from daily routine were used in the determination of within-run imprecision and for method comparison. In accordance with the Clinical Laboratory Standard Institute (CLSI) guideline EP9-A2 [6] , 40 fasting fresh serum samples from left-over patient specimens were collected over 5 operating days (8/day). Lipemic and hemolyzed samples were excluded. All samples were stored at -20°C and analyzed within 1 week of collection. This study was approved by the Clinical Research Ethics Committee of Tianjin Medical University General Hospital.
Methods comparison
All 40 samples were run in duplicate by three diagnostic systems. Aliquots of each sample were analyzed sequentially in the first run and then reversed. Results of measurements were compared following CLSI guideline EP9-A2 [6] .
Imprecision evaluation
Before the start of the comparison, the imprecisions of three routine methods were evaluated using a serum pool of three concentrations total bilirubin. The concentrations of the three serum pools were near the medical decision points (Xc = 25 µmol/L, 50 µmol/L, and 340 µmol/L). Each sample was measured 5 times a day for 5 days by three concentrations bilirubin [4] .
Reference system
The Cobas 8000 (Diazo method) for both total bilirubin and direct bilirubin is a "closed system" with only 10 open channels, two thirds of our routine samples were detected by this device and are traceable, and comprehensive External Quality Control data is available; it was considered as the reference system. The Cobas8000 system (vanadate oxidase method) and Ortho VITROS 5600 (Dry chemistry method) were perceived as the test system and separately compared with the Cobas 8000 (Diazo method).
Statistical methods
All data were evaluated using IBM SPSS Statistics for Windows, Version 19.0 (IBM Corp; Armonk, NY, USA). Imprecision was calculated in accordance with CLSI guidelines EP-15A [7] . The correlation and bias of each analyte between the reference system and test systems were evaluated and calculated by linear regression and Bland and Altman plot. The predicted bias and the 95% confidence intervals for bias were computed as well. The acceptable bias range was calculated using the 1/2 allowable error as described in CLIA'88 [8] . If the acceptable bias was greater than the higher limit of the 95% confidence intervals of the predicted bias, the performance of the evaluated method would be assumed to be the equivalent to the reference system and deemed acceptable for the defined application.
RESULTS

Performance of three routine methods
The imprecision was evaluated using a serum pool of three concentrations of total bilirubin near the medical decision points and the results are shown in Table 1 . The within-run precisions of total bilirubin range from 0.7% to 3.03%. The intermediate precisions of total bilirubin range from 1.31% to 5.09%. Although the dry chemistry method intermediate imprecision of CV was high at 5.09%, it still met the CLIA'88 requirement [8] of bilirubin measurement (1/3*20%). Except for the dry chemistry method, both the diazo method and vanadate oxidase method were used for the detection of direct bilirubin. The within-run precisions of direct bilirubin range from 1.20% to 3.62%. The intermediate precisions of direct bilirubin range from 1.31% to 4.03% (Table 1) . Table 2 shows the linear regression analysis of the diazo method vs. vanadate oxidase and dry chemistry methods for the measurement of serum total bilirubin or direct bilirubin. Very close correlations were obtained between the results of different methods for both total bilirubin and direct bilirubin. For total bilirubin, the slopes of the equations were between 0.827 and 0.975, with correlation coefficients ranging from 0.995 to 0.999. For direct bilirubin, the equation between diazo method and vanadate oxidase method is y = 0.827 x + 1.925 (r 2 = 0.998). Predicted bias and the 95% predicted bias confidence intervals at medical decision points between these three routine methods were shown in Table 2 and  Table 3 . The 95% predicted bias confidence intervals between diazo method and vanadate oxidase method for total bilirubin were less than the acceptable bias and was acceptable for the defined application. However, for direct bilirubin the 95% predicted bias confidence intervals was only acceptable at the medium medical decision point (Xc = 6 µmol/L) ( Table 2 ). The 95% predicted bias confidence intervals between diazo method and dry medical method for total bilirubin were all acceptable (Table 3 ). Figure 1 shows the difference between the three routine methods for the measurement of serum bilirubin according to the Bland-Altman plot. The differences between methods increased with the serum bilirubin concentration. Both vanadate oxidase method and dry chemistry method compared with the diazo method as follows: vanadate oxidase method showed a slight negative bias with mean ± SD of -3.87 ± 9.07 µmol/L and -5.65 ± 13.84 µmol/L for total bilirubin and direct bilirubin, repectively; dry chemistry method showed a positive deviation with mean ± SD of 8.71 ± 6.15 µmol/L. Compared with the dry medical method, vanadate oxidase method showed more negative bias with mean ± SD of -12.6 ± 8.90.
Method comparison
DISCUSSION
The lack of standardization and/or harmonization between chemistry assays utilized in the clinical laboratory is an area of widespread concern [9] . With bilirubin measurements as a typical example, we focused on the inter-assay variability that is frequently applied to the same bilirubin treatment decision graph. In this study, we compared the vanadate oxidase method on the Cobas 8000 analyzer (non-homogeneous system), diazo method on the Cobas 8000 analyzer (homogeneous system), and dry chemistry method on the VITRO 5600 (homogeneous system) for the measurement of serum bilirubin.
The results of our study showed that the vanadate oxidase method and dry chemistry method displayed an excellent correlation with the diazo method for both serum total bilirubin and direct bilirubin ( Table 2 and Table 3 ). However, the increasing differences were observed between methods with higher concentration of serum bilirubin. Compared to the diazo method (wet chemistry method), the dry chemistry method showed a positive deviation. The bias observed between the wet and dry chemical methods is not new. Hongwei Fu et al. [10] found discrepancies up to 30% for ALT, AST, and ALP measurements in a Chinese lab between wet chemistry and dry chemistry analyzers. In this study, the difference was up to 16% of total bilirubin at the concentration of 340 µmol/L. First, the discrepancies can be explained, in part, by differences in the structural forms of "bilirubin" that are quantified by each method [10] . Second, the different calibration curves for methods also count for the bias. Both diazo method (wet chemistry method) and dry chemistry methods for total bilirubin are diazo-based techniques. However, for the diazo method (wet chemistry method) using transmission spectrophotometry, the absorbance vs. concentration shows a linear relationship, following Beer-Lambert law. While for dry chemistry methods for total bilirubin by reflectance spectrophotometry, the relationship between absorbance and concentration is not linearly proportional, following Williams-Clapper law. Thus, diazo method (wet chemistry method) and dry chemistry methods compare only at a certain concentration and it could not be adjusted by a mathematical factor correction method. The result in this study also shows these two methods compared well at the concentrations at reference intervals and near the upper limit. Therefore, these differences between the results obtained by these 2 methods do not have significant consequence for clinical diagnosis. But, for therapeutic monitoring, it is wise to use the mono-platform for clinicians to make critical decisions and inter-platform harmonization should be strongly encouraged. Third, persisting inaccuracies and variability in laboratory performance of serum bilirubin measurement can be traced to reference material and method [11] . The reference method of the diazo method (wet chemistry method) in this study is the Doumas reference measurement procedure. For dry chemistry methods of total bilirubin, the reference method is the Jendrassik-Grof method, and it establishes traceability of their working calibration standards to SRM 916a, a bilirubin calibrator prepared by the USA National Institute of Standards and Technology (NIST). Although, traceability of these 2 methods are both at a high standard level, the specific reference material and method are different. So, very close correlations were observed between these 2 methods but the differences were high with the increasing concentration of total bilirubin. Although traceability has been gradually accepted in China, our traceability system is still immature. In clinical chemistry analyses, only a few analytes (e.g., glucose, cholesterol, creatinine, potassium) can now be traced to the International System of Units (SI). Meanwhile, the non-homogeneous system and non-matched calibrators are still commonly used [5] . In this study, we also evaluated and compared clinical results of the diazo method (the homogeneous system) and vanadate oxidase method (the non-homogeneous system) for the measurement of serum bilirubin. According to the assessment criteria per CLSI EP-9A, the CIs of the predicted bias of the vanadate oxidase method were less than the limit of the acceptable error at the three medical decision points (Table 2) . However, for the result of direct bilirubin, the CIs of the predicted bias was acceptable only at the low medical decision points (Xc = 6 µmol/L). Although the cause for these biases remains unclear, the bias may partially be related to the method of low level calibration traceability for direct bilirubin.
CONCLUSION
Serum bilirubin is one parameter with high laboratory variability since its discovery up to the present. Our study evaluated and compared analytical performance and clinical results of three routine methods for serum bilirubin in a Chinese laboratory. All three evaluated routine methods for serum bilirubin in our lab were closely correlated. Further studies are required to reduce the biases between these methods.
